BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company





BioTime, Inc. (NYSE American and TASE: BTX), and Asterias

Biotherapeutics, Inc. ("Asterias") (NYSE American: AST), today announced

that they have entered into a definitive merger......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 8 November
Share |